ENDEFR
Home › Czechia › Dr. Kulich Pharma, s.r.o.

Dr. Kulich Pharma, s.r.o.

Společnost s ručením omezeným · Hradec Králové, Czechia · LEI 315700528ILYAO901X22
LEI active

Summary

Dr. Kulich Pharma, s.r.o. is registered in Czechia and entered in the “Commercial Register (Obchodní rejstřík)” under number 27487555. Its legal form is Společnost s ručením omezeným – private limited company (Czechia). According to GLEIF, its ultimate parent is Fagron (Belgium), and its direct parent is Fagron B.V. (Netherlands). That group has 4 subsidiaries with LEIs in 3 countries, 2 of them in Czechia. The LEI was first issued on 20 Jan 2022 and the record was last updated on 23 Apr 2026; the next renewal is due by 3 Mar 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formSpolečnost s ručením omezeným
private limited company (Czechia)
RegisterCommercial Register (Obchodní rejstřík) · Register website
Registration number27487555
Registration authorityMinistry of Justice
JurisdictionCzechia
Registered addressPiletická 178/61, 500 03 Hradec Králové, Czechia
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)20 Jan 2006
LEI315700528ILYAO901X22
LEI statusactive
LEI first issued20 Jan 2022
LEI record last updated23 Apr 2026
Next LEI renewal3 Mar 2027
Corroboration of the LEI recordfully corroborated

Group membership

Fagron Belgium ultimate parent
Fagron B.V. Netherlands direct parent
Dr. Kulich Pharma, s.r.o. this entity
View the whole group: 4 subsidiaries in 3 countries

Relationship to the parent

Direct parentUltimate parent
ParentFagron B.V.Fagron
Accounting period1 Jan 2024 to 31 Dec 20241 Jan 2024 to 31 Dec 2024
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Accounting standardIFRSIFRS
Consolidation percentage reported to GLEIF100.00%100.00%
Relationship start23 Feb 202423 Feb 2024
Recorded at GLEIF since23 Feb 202412 Jan 2022
Last updated3 Mar 20263 Mar 2026
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (1)